Three million members of CVS Caremarks clients now enjoy access to clinical weight loss program with proven results, high satisfaction WOONSOCKET, R.I., March 14, 2025 CVS Health (NYSE: CVS) released compelling data today from the CVS Weight Management TM program in which participants achieved more than 15% weight loss on average, including existing anti-obesity medication users who succeeded in nearly doubling their pre-program weight loss while working with program clinicians on diet and lifestyle.* Before enrolling in the CVS Weight Management program, 70% of members were using a weight management drug without any lifestyle or nutrition support.* The initial results demonstrate improved weight loss and high program satisfaction for CVS Caremark clients' plan members trying a lifestyle-first approach and additional clinical effectiveness and cost savings for members receiving clinical support while taking weight management medications like GLP-1s
Developed by Nexus Pharma, the brand teams its primary ingredient glutathione with other science-backed actives like Vitamin C, niacinamide and hyaluronic acid to create multitasking formulas that treat common skin concerns such as hyperpigmentation and dryness
Secoisolariciresinol diglucoside of flaxseed and its metabolites: biosynthesis and potential for nutraceuticals
Anti-Aging effects Researchers consider oxidative stress an important factor in the aging process
Understanding the Klow Peptide Blend: Composition and Mechanism The Klow peptide blend is a proprietary formulation, typically composed of several distinct peptides chosen for their synergistic effects in specific biological pathways
